JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 6 1066-1069
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Werner, E.
Right arrow Articles by Reiners, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Werner, E.
Right arrow Articles by Reiners, C.

Reproducibility of Technetium-99m-MAG3 Clearance Using the Bubeck Method

Edgar Werner, Christiana Blasl and Christoph Reiners

Clinic for Nuclear Medicine, University of Würzburg, Würzburg, Germany

Correspondence: For correspondence or reprints contact: Edgar Werner, MD, Clinic for Nuclear Medicine, University of Würzburg, Josef Schneiderstr. 2, 97080 WürZburg, Germany.

ABSTRACT

The objective of this study was to estimate the reproducibdity of 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) clearance calculated usinga single-sample method. Methods: One hundred forty-seven patients with urological or ear, nose and throat cancer were analyzed in a retrospective study. Each patient had at least two clearance studies with 99mTc-MAG3 before chemotherapy treatments to monitor renal function. Up to five clearance studies per patient were considered. The reproduability was estimated by comparing two consecutive investigations. Pairs of investigations with a change in split renal function of more than 5% or an interval of more than 50 days were exduded. Clearance was determined using the Bubeck method. For each pair of consecutive clearance data, the difference between the first and the second measurements was expressed as a percentage of the mean value of the two measurements. The mean of these normalized differences represents the systematic deviation, and the s.d. represents the reproducibility of the compared clearances. Results: After the selection, 242 pairs of consecutive clearance data remained for comparison. Significantly different clearances were observed only between investigations 0 and 1 and between 4 and 5. The systematic deviation of these comparisons totaled –3.8% and –5.7%, respectively. In the other comparisons no significant deviation induced by the chemotherapy was found. The reproducibility calculated for all comparisons totaled 11.7%. ConclusIon: The error of reproducibility of 99mTc-MAG3 clearance using the Bubeck method was ≥11.7%. This was an acceptable value, taking into account the greater fluctuation of tubular function compared with the glomerular filtration rate.

Key Words: clearance studies • technetium-99m-MAG3 • Bubeck method







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.